The field of neurotoxicology is evolving, with advancements in biomarker development, computational modeling, and alternative testing methods contributing to more accurate risk assessments. Understanding the genetic and epigenetic factors that influence susceptibility to neurotoxins is a growing area of research. Furthermore, public health initiatives are increasingly focused on reducing environmental exposures and promoting brain health across the lifespan.
In conclusion, neurotoxic substances represent a complex challenge within toxicology. By advancing our understanding of these agents and implementing robust prevention and treatment strategies, we can better protect the nervous system and enhance public health outcomes.
